Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today shared updates from its clinical programs focused on limb-girdle muscular dystrophy (LGMD) subtypes 2C/R5 ...

Despite the PNG award termination, GeoVax anticipates a milestone-rich 2025 across its portfolio. The Company will continue to engage with government and industry partners, pursue clinical trial ...

By Edward Adjei FRIMPONG African leaders must adopt innovative strategies to attract private sector investment to boost ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Q4 2024 Earnings Conference Call April 9, 2025 8:00 AM ET. Company Participants. Frank Mathias - Chief Executive Officer Sebastien Ribault - Chi ...

Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

Bioprocessing has always been a bit late in adopting the latest engineering techniques, e.g., computational fluid dynamics to ...

Reports FY24 revenue GBP 128.8M vs. GBP 89.5M last year. Frank Mathias, CEO of OXB, commented: “2024 was a year of strong commercial progress for ...

Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD's Innovative Dual-Targeting CAR-T Therapy, "P134 Cell Injection," which has received Investigational New Drug (IND) ...

We explore the concept of AI factories as the engine driving the next industrial revolution, with NVIDIA pioneering ...

You can see the future first in San Francisco. Over the past year, the talk of the town has shifted from $10 billion compute clusters to $100 billion clusters to trillion-dollar clusters. Every six ...

Can Unity Software catalyze its valuation with a new CEO, scrapped pricing plan, and the launch of its Vector AI platform for ...